Delivery Order SPE2DB20D1100-SPE2DB25FA7T1
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,522.78 delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product, and has a completion date of December 18, 2024. The contract is a firm fixed price delivery order and was not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,441.80, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,592.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of January 25, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,384.48, is a delivery order for MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication. The contract is a firm fixed-price agreement with a completion date of February 24, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,999.10, is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,728.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of March 12, 2024. This appears to be a delivery order contract with a firm fixed price. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $7,146.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,669.00, is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. It is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, solicited by the Defense Logistics Agency (DLA), was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,698.83, is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a term through January 3, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,384.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...